These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3527418)

  • 1. Basic principles for utilizing combination differentiation agents.
    Waxman S; Scher W; Scher BM
    Cancer Detect Prev; 1986; 9(3-4):395-407. PubMed ID: 3527418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
    Scher BM; Scher W; Waxman S
    Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
    Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE
    J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ligase and DNase activities in mouse erythroleukemia cells during dimethyl sulfoxide-induced differentiation.
    Scher BM; Scher W; Robinson A; Waxman S
    Cancer Res; 1982 Apr; 42(4):1300-6. PubMed ID: 6949637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible involvement of calcium metabolism.
    Tsiftsoglou AS; Mitrani AA; Housman DE
    J Cell Physiol; 1981 Sep; 108(3):327-35. PubMed ID: 6793604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteases act synergistically with low molecular weight inducers to stimulate mouse erythroleukemia cell differentiation.
    Scher W; Scher BM; Waxman S
    Exp Hematol; 1983 Jul; 11(6):490-8. PubMed ID: 6352299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS; Wong W
    Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionic regulation of MEL cell commitment.
    Levenson R; Macara I; Cantley L; Housman D
    J Cell Biochem; 1983; 21(1):1-8. PubMed ID: 6575972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention.
    Ebisuzaki K
    Anticancer Res; 2003; 23(1A):453-8. PubMed ID: 12680248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation.
    Ai Z; Misra S; Susa M; Varticovski L; Cohen CM
    Exp Cell Res; 1995 Aug; 219(2):454-60. PubMed ID: 7641797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
    Lubin M
    J Cell Physiol; 1985 Sep; 124(3):539-44. PubMed ID: 3862669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
    Chen ZX; Breitman TR
    Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones.
    Jing Y; Waxman S
    Anticancer Res; 1995; 15(4):1147-52. PubMed ID: 7653993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differentiation inducer, dimethyl sulfoxide, transiently increases the intracellular calcium ion concentration in various cell types.
    Morley P; Whitfield JF
    J Cell Physiol; 1993 Aug; 156(2):219-25. PubMed ID: 8393876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR; Singh LP; Wahba AJ
    Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.